474
Participants
Start Date
March 26, 2018
Primary Completion Date
March 8, 2019
Study Completion Date
March 8, 2019
JNJ-64565111 Dose Level 1
Participants will receive JNJ-64565111 Dose Level 1 SC once -weekly until Week 26.
JNJ-64565111 Dose Level 2
Participants will receive JNJ-64565111 Dose Level 2 SC once-weekly until Week 26.
JNJ-64565111 Dose Level 3
Participants will receive JNJ-64565111 Dose Level 3 SC once-weekly until Week 26.
Liraglutide
Participants will receive liraglutide at a starting dose of 0.6 mg then dose will be ramped up by 0.6 mg daily until reaching 3.0 mg. Participants will then continue on the 3.0 mg once-daily dosage until Week 26.
Placebo
Participants will receive matching placebo SC once-weekly until Week 26.
UZ Antwerpen, Edegem
UZ Leuven, Leuven
Practimed Medical Center, Tessenderlo
CHU de Liège, Liège
CSL Arlon, Arlon
AZ Delta, Roeselare
OLV Ziekenhuis Aalst, Aalst
AZ Glorieux Ronse, Ronse
Weill Cornell Medicine, New York
Central New York Clinical Research, Manlius
PharmaSite, Malmo
PharmaSite, Helsingborg
Coastal Carolina Research Center, Mt. Pleasant
Care Partners Clinical Research, Jacksonville
L-Marc Research Center, Louisville
Intern Medicin, Gothenburg
PTC,Primary care Trial Center, Gothenburg
Rapid Medical Research, Cleveland
Medisphere Medical Research Center, Llc, Evansville
Katarina Berndtsson-Blom Ladulaaskliniken, Borås
Allegiance Reserach Specialists, LLC, Wauwatosa
Dallas Diabetes Research Center, Dallas
Permian Research Foundation, Odessa
Advanced Clinical Research, Boise
Advanced Clinical Research, West Jordan
Central Phoenix Medical Clinic, Phoenix
Diablo Clinical Research, Inc., Walnut Creek
Rainier Clinical Research Center, Renton
Milford Emergency Associates, Inc., Marlborough
Omega Medical Research, Warwick
Joanne F. Liutkus Medicine Professional Corporation, Cambridge
Canadian Phase Onward, Toronto
Dr. Anil K Gupta Medicine Professional Corporation, Toronto
Manna Research, Toronto
Manna Research, Lévis
Manna Research, Pointe-Claire
Clinique des Maladies Lipidiques de Québec, Québec
Indywidualna Praktyka Lekarska, Gabinet Leczenia Otyłości i Chorób Dietozależnych, Bialystok
Centrum Badań Klinicznych PI-House sp. z o.o., Gdansk
NZOZ 'Linia' Centrum Leczenia Zaburzeń Metabolicznych Magdalena Olszanecka-Glinianowicz, Katowice
Nzoz Salvia, Katowice-Ligota
Centrum Zdrowia Metabolicznego Paweł Bogdański, Poznan
Avdelningen för kliniska prövningar, Örebro
PTC- Skaraborg, Skövde
Southmead Hospital, Bristol
Ashgate Medical Practice, Chesterfield
Hathaway Medical Centre, Chippenham
Aintree University Hospital NHS Trust, Liverpool
Clifton Medical Centre, Rotherham
Albany House Medical Centre, Wellingborough
Bradford on Avon and Melksham Health Partnership, Wiltshire
Janssen Research & Development, LLC
INDUSTRY